"Uveitis, Intermediate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Inflammation of the pars plana, ciliary body, and adjacent structures.
Below are MeSH descriptors whose meaning is more general than "Uveitis, Intermediate".
Below are MeSH descriptors whose meaning is more specific than "Uveitis, Intermediate".
This graph shows the total number of publications written about "Uveitis, Intermediate" by people in Harvard Catalyst Profiles by year, and whether "Uveitis, Intermediate" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 0 | 1 |
1999 | 1 | 0 | 1 |
2001 | 1 | 0 | 1 |
2005 | 1 | 0 | 1 |
2011 | 1 | 0 | 1 |
2012 | 1 | 0 | 1 |
2013 | 1 | 0 | 1 |
2014 | 1 | 0 | 1 |
2015 | 1 | 0 | 1 |
2016 | 1 | 0 | 1 |
2020 | 2 | 0 | 2 |
2021 | 2 | 0 | 2 |
Below are the most recent publications written about "Uveitis, Intermediate" by people in Profiles.
-
Assessing the Uniformity of Uveitis Clinical Concepts and Associated ICD-10 Codes Across Health Care Systems Sharing the Same Electronic Health Records System. JAMA Ophthalmol. 2021 Aug 01; 139(8):887-894.
-
Risk of Cataract in Intermediate Uveitis. Am J Ophthalmol. 2021 09; 229:200-209.
-
Incidence and Outcome of Uveitic Glaucoma in Eyes With Intermediate, Posterior, or Panuveitis Followed up to 10 Years After Randomization to Fluocinolone Acetonide Implant or Systemic Therapy. Am J Ophthalmol. 2020 11; 219:303-316.
-
Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 2: Guidelines for Initiating Antitubercular Therapy in Anterior Uveitis, Intermediate Uveitis, Panuveitis, and Retinal Vasculitis. Ophthalmology. 2021 02; 128(2):277-287.
-
Phakic intraocular lens as a temporary barrier in aphakic Descemet's membrane endothelial keratoplasty. Eur J Ophthalmol. 2019 Sep; 29(5):566-570.
-
Remission of Intermediate Uveitis: Incidence and Predictive Factors. Am J Ophthalmol. 2016 Apr; 164:110-7.e2.
-
Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study. Ophthalmology. 2015 Oct; 122(10):1967-75.
-
Intermediate uveitis: an unusual presentation of cytomegalovirus intraocular infection in an immunocompetent patient. BMJ Case Rep. 2015 May 12; 2015.
-
Cost-effectiveness of fluocinolone acetonide implant versus systemic therapy for noninfectious intermediate, posterior, and panuveitis. Ophthalmology. 2014 Oct; 121(10):1855-62.
-
Fluorescein angiography versus optical coherence tomography for diagnosis of uveitic macular edema. Ophthalmology. 2013 Sep; 120(9):1852-9.